GetTopicDetailResponse(id=2924118492a2, topicName=Olpasiran, introduction=, content=動脈粥樣硬化 脂蛋白（a） Olpasiran, image=null, comments=0, allHits=640, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Thu Aug 29 13:14:42 CST 2024, time=2024-08-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=465350, tagList=[TagDto(tagId=465350, tagName=Olpasiran)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2252976, encodeId=3c4122529e6dc, content=<a href='/topic/show?id=b16d11032029' target=_blank style='color:#2F92EE;'>#脂蛋白（a）#</a> <a href='/topic/show?id=2924118492a2' target=_blank style='color:#2F92EE;'>#Olpasiran#</a>, objectTitle=3個月用藥一次，強效降脂92%，效果持續(xù)1年！或有助于預(yù)防動脈粥樣硬化, objectType=article, longId=864077, objectId=8cb68640e777, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240603/1717404163024_5579292.jpg, objectUrl=/article/show_article.do?id=8cb68640e777, replyNumber=0, likeNumber=30, createdTime=2025-02-21, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=8cb68640e777, moduleTitle=3個月用藥一次，強效降脂92%，效果持續(xù)1年！或有助于預(yù)防動脈粥樣硬化, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8cb68640e777)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2223010, encodeId=eee12223010a6, content=<a href='/topic/show?id=98773329350' target=_blank style='color:#2F92EE;'>#動脈粥樣硬化#</a> <a href='/topic/show?id=b16d11032029' target=_blank style='color:#2F92EE;'>#脂蛋白（a）#</a> <a href='/topic/show?id=2924118492a2' target=_blank style='color:#2F92EE;'>#Olpasiran#</a>, objectTitle=降脂近50%！JACC：siRNA長效療法，打四針，療效維持近1年, objectType=article, longId=840925, objectId=2dc98409250c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240711/1720665035747_5579292.png, objectUrl=/article/show_article.do?id=2dc98409250c, replyNumber=0, likeNumber=119, createdTime=2024-08-29, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=2dc98409250c, moduleTitle=降脂近50%！JACC：siRNA長效療法，打四針，療效維持近1年, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=2dc98409250c)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-08-29發(fā)表于上海
